Select Medical Reports Strong Q2 2025 Financial Results

Select Medical ( (SEM) ) has issued an update.

Select Medical Holdings Corporation announced its financial results for the second quarter of 2025, reporting a 4.5% increase in revenue to $1,339.6 million and a significant 53.8% rise in net income from continuing operations to $57.9 million compared to the previous year. The company also declared a cash dividend of $0.0625 per share, payable on August 28, 2025, and announced a stock repurchase program to buy back up to $1.0 billion worth of shares, reflecting its robust financial performance and commitment to returning value to shareholders.

The most recent analyst rating on (SEM) stock is a Buy with a $21.00 price target. To see the full list of analyst forecasts on Select Medical stock, see the SEM Stock Forecast page.

Spark’s Take on SEM Stock

According to Spark, TipRanks’ AI Analyst, SEM is a Neutral.

Select Medical’s overall score reflects moderate financial performance with strong cash flow. The stock is undervalued with a decent dividend yield, but technical indicators suggest a downward trend in the short term. Despite growth in certain divisions, regulatory challenges and adverse weather have impacted performance. The company’s strategic growth plans and positive earnings guidance provide a balanced outlook.

To see Spark’s full report on SEM stock, click here.

More about Select Medical

Select Medical is a leading operator of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics across the United States. The company operates 104 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,919 outpatient rehabilitation clinics in 39 states and the District of Columbia.

Average Trading Volume: 1,316,888

Technical Sentiment Signal: Sell

Current Market Cap: $1.83B

For an in-depth examination of SEM stock, go to TipRanks’ Overview page.